Document is current
Any future updates will be listed below
-
Authors
Wright, Sarah N https://orcid.org/0000-0003-3441-5469
Yang, Jane
Ideker, Trey https://orcid.org/0000-0002-1708-8454
-
Funding
Funding for this research was provided by:
HHS | NIH | National Institute on Drug Abuse (P50 DA037844)
HHS | NIH | National Institute of Mental Health (U01 MH115747)
California Institute for Regenerative Medicine (ReMIND DISC4-16322)
California Institute for Regenerative Medicine (ReMIND DISC4-16377)
- License Information
-
More Information
Article History
Received: 18 November 2025
Revised: 25 January 2026
Accepted: 12 February 2026
First Online: 26 March 2026
Disclosure and competing interests statement
: TI is a co-founder, member of the advisory board, and has an equity interest in Data4Cure and Serinus Biosciences. TI is a consultant for and has an equity interest in Ideaya Biosciences and Eikon Therapeutics. The terms of these arrangements have been reviewed and approved by the University of California, San Diego, in accordance with its conflict-of-interest policies.
